Clinical Trials Browser

Phase 3 × Completed × Megestrol Acetate × Clear all

NCT00006799 2021-09-09

Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer

Phase 3 Completed

Squamous Cell Carcinoma of Head and Neck, Anorexia, Cachexia, Head and Neck Neoplasms, Esthesioneuroblastoma, Olfactory

NCT00031785 2021-09-09

Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer

Phase 3 Completed

Anorexia, Cachexia, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00070148 2021-09-09

Oxandrolone Compared With Megestrol in Preventing Weight Loss in Patients Receiving Chemotherapy for Cancer

Phase 3 Completed

Body Weight Changes

NCT00031707 2016-07-14

Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite

Phase 3 Completed

Anorexia, Cachexia

NCT00005975 2015-11-18

S9626: Megestrol in Treating Hot Flashes Following Treatment for Breast Cancer

Phase 3 Completed

Breast Neoplasms, Hot Flashes

NCT00041275 2013-09-20

Megestrol in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

Phase 3 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01237327 2011-05-06

Multicenter Follow Up Study Of Subjects Who Participated In An Original Protocol Of Exemestane Vs. Megestrol Acetate In Postmenopausal Women With Metastatic Breast Cancer

Phase 3 Completed

84 enrolled 12 charts

Breast Neoplasms